Purchase Order 75N92025P00084

The National Heart Lung and Blood Institute (NHLBI), a component of the Department of Health and Human Services, awarded a $25,900 firm fixed-price purchase order contract to QPS LLC, a minority-owned limited liability company, for the "Evaluation of R406 Levels in a Non-Human Primate Model of Bacterial Sepsis." This research and development contract, awarded on March 6, 2025, supports NHLBI's efforts to study bacterial sepsis progression and potential therapeutic interventions using non-human primate models. QPS LLC is an experienced biotechnology research services provider that has previously supported federal health research initiatives, including work for the National Institute of Neurological Disorders and Stroke and the National Center for Advancing Translational Sciences. The contract does not have a small business set-aside designation, indicating that QPS LLC competed successfully in an open competition. The research will likely involve sophisticated laboratory analysis, such as liquid chromatography-mass spectrometry, to evaluate the levels of the compound R406 in the non-human primate sepsis model.